Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Recombinant human TWEAK protein (ab9968)

Price and availability

197 673 ₸

Availability

Order now and get it on Friday March 05, 2021

Key features and details

  • Expression system: Escherichia coli
  • Endotoxin level:
  • Active: Yes
  • Suitable for: Functional Studies, SDS-PAGE

You may also be interested in

Product image
Anti-Cdc27 antibody [AF3.1] (ab10538)
Product image
Anti-LPHN3 antibody (ab150794)
Product image
Anti-KLHL13 antibody (ab230264)
Product image
Recombinant Human CLPTM1L protein (ab164317)

Preparation and Storage

  • Alternative names

    • APO 3 ligand
    • APO 3L
    • APO3 ligand
    • APO3/DR3 ligand
    • APO3L
    • DR3LG
    • MGC129581
    • MGC20669
    • secreted form
    • TNF-related weak inducer of apoptosis
    • TNF12_HUMAN
    • TNFSF 12
    • Tnfsf12
    • TNFSF12 protein
    • Tumor necrosis factor (ligand) superfamily member 12
    • Tumor necrosis factor ligand superfamily member 12
    • Tumor necrosis factor superfamily member 12
    • TWEAK
    • UNQ181/PRO207
    see all
  • Function

    Binds to FN14 and possibly also to TNRFSF12/APO3. Weak inducer of apoptosis in some cell types. Mediates NF-kappa-B activation. Promotes angiogenesis and the proliferation of endothelial cells. Also involved in induction of inflammatory cytokines.
  • Tissue specificity

    Highly expressed in adult heart, pancreas, skeletal muscle, brain, colon, small intestine, lung, ovary, prostate, spleen, lymph node, appendix and peripheral blood lymphocytes. Low expression in kidney, testis, liver, placenta, thymus and bone marrow. Also detected in fetal kidney, liver, lung and brain.
  • Sequence similarities

    Belongs to the tumor necrosis factor family.
  • Post-translational
    modifications

    The soluble form derives from the membrane form by proteolytic processing.
  • Cellular localization

    Secreted and Cell membrane.
  • Target information above from: UniProt accession O43508 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt

Images

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Recombinant human TWEAK protein (ab9968)

  •  
  • Recombinant Pig TWEAK protein (ab169719)

    Applications: SDS-PAGE

  •  
  • Product image

    TWEAK overexpression 293T lysate (whole cell) (ab94113)

    Applications: WB

  •  
  • Recombinant human TWEAK protein (Animal Free) (ab217458)

    Applications: FuncS, HPLC, SDS-PAGE

  •  
  • Recombinant Mouse TWEAK protein (ab184591)

    Applications: ELISA, SDS-PAGE, WB

  •  
  • Recombinant Dog TWEAK protein (ab177569)

    Applications: ELISA, SDS-PAGE, WB

Clear all

Recently viewed products

  •  
  • Product image

    Mouse Interferon alpha 2 Matched Antibody Pair Kit (ab215409)

  •  
  • Product image

    Monkey MCP1 ELISA Kit (ab242231)

  •  
  • Product image

    Anti-DTN-B antibody (ab217543)

  •  
  • Product image

    Recombinant Human EMP2 protein (ab152364)

  •  
  • Product image

    Recombinant human SFT protein (Active) (ab269096)

  •  
  • Product image

    Human MAP3K1 knockout HeLa cell line (ab265505)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.